Laid the foundation of Adley Group by Late Shri. Vijay Batra
Committed to Healthcare
Because, every moment of life is precious...
We at Medyra Pharmaceuticals Ltd, Strive for Affordability Accessibility Acceptability of medicines
Our Vision
To achieve a sustainable leadership in complex chemical synthesis for Anti-Cancer bulk drups and finishes dosages.
Our Mission
To touch the lives of millions of cancer patients by expanding access to Quality & affordable drugs through cutting edge technology and advance R&D.
Our Promises
Our Values
Cost Effectiveness
We believe healthcare is only effective when it’s affordable, hence we put in extra efforts in ensuring that we make cost effective products by achieving economy of scale and backward integration.
Collaboration & Partnerships
We firmly believe, Success is best when it’s shared and hence we consider everyone who associates with us i.e. patients, industry partners, and the communities associated with us, as partners.
Care
We care about the well-being of our patients, care givers, and the communities we touch. We care about our colleagues, creating a respectful, inclusive and a diverse working environment.
Patient First
We understand patients, and how fighting a disease takes a toll on them, so every step we take is in the direction to try and make this fight easier, by focusing on driving better treatment outcomes and not compromising on quality & affordability.
Value through innovation
We constantly innovate to create better value for our patients, our partners in the healthcare system and our stakeholders. We persistently focus on originality and try to find better ways to excel by creating products for current and future unmet needs.
Focus & Accountability
We believe that as leaders we set the right example by focusing diligently on everything we do by defining clear objectives, efforts and attention to deliver. We always hold ourselves accountable to the promises we make through our products & research.
Leading the Way
We are passionate about being first to market and realizing opportunities, but we also ensure that we lead by example as leadership happens through and with the people.
Our Milestones
1993
2007
Entered into Oncology Market
2008
Setup the first Oncology Unit in Adley Formulations Pvt Ltd.
2011
Foray into the international market
2014
Setup a new "state of the art" manufacturing facility for oncology formulations.
2015
Developed in-house Albumin bound Paclitaxel.
2017
Received SME Excellence Award
Listed in NSE - National Stock Exchange
Commenced In-house API Plant - Adley Labs
2018
Setup an oncology plant in Uzbekistan.
2020
Setup Inhouse PFS Facility
Launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB
Launched 1st Indian Brand of Dasatinib, BEEDAN
2021
Launched 1st Indian brand of Sunitinib, ADSUNIB.